Australia seems poised to experience a groundbreaking treatment for excess weight: Retatrutide. The dual molecule – working on both GLP-1 and GIP receptors – demonstrates remarkable efficacy in global studies, pointing to considerable drops in BMI. While regulatory clearance is pending with the Therapeutic Goods Administration (TGA), several pe